Literature DB >> 11120336

No evidence of increased chromosomal aberrations and micronuclei in lymphocytes from nonfamilial thyroid cancer patients prior to radiotherapy.

O M Gil1, N G Oliveira, A S Rodrigues, A Laires, T C Ferreira, E Limbert, J Rueff.   

Abstract

The relationship between the presence of high frequencies of chromosomal aberrations in peripheral lymphocytes and predisposition to cancer has been suggested for some cancer diseases. In nonfamilial thyroid cancer, the few reports available are equivocal. The aim of this study was to assess the possible chromosomal instability in peripheral blood lymphocytes from 22 patients suffering from nonfamilial thyroid cancer. For this purpose, 2 classic cytogenetic assays, the chromosomal aberrations assay and cytokinesis-blocked micronucleus assay, were chosen. The frequency of chromosomal aberrations excluding gaps (%) was 1.68 +/- 1.39 (mean value +/- SD) for the patients group versus 2.20 +/- 1.87 for the control group. The frequency of binucleated lymphocytes with micronuclei ( per thousand) was 5.41 +/- 3.51 (mean value +/- SD) for the patients group versus 5.37 +/- 3.21 for the control group. The results obtained revealed no significant differences between both groups. The present study reinforces the idea that constitutional chromosomal instability in peripheral blood lymphocytes is not visible in nonfamilial thyroid carcinomas.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11120336     DOI: 10.1016/s0165-4608(00)00305-8

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  6 in total

1.  Mutagenicity of diagnostic and therapeutical doses of radiopharmaceutical iodine-131 in Wistar rats.

Authors:  Elisângela Düsman; Alessandra Paim Berti; Rosinete Gonçalves Mariucci; Nilson Benedito Lopes; Veronica Elisa Pimenta Vicentini
Journal:  Radiat Environ Biophys       Date:  2011-08-25       Impact factor: 1.925

2.  Micronucleus frequency among Iraqi thyroid disorder patients.

Authors:  Abdul Hussein Moyet AlFaisal; Intesar Jawad Kahdoom Al-Ramahi; Ismail Abdul Redah Abdul-Hassan
Journal:  Comp Clin Path       Date:  2012-12-28

3.  No evidence of chromosome damage in children and adolescents with differentiated thyroid carcinoma after receiving 131I radiometabolic therapy, as evaluated by micronucleus assay and microarray analysis.

Authors:  Giovanni Federico; Giuseppe Boni; Barbara Fabiani; Lisa Fiore; Patrizia Lazzeri; Francesco Massart; Claudio Traino; Carmela Verola; Giuseppe Saggese; Giuliano Mariani; Roberto Scarpato
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-07-22       Impact factor: 9.236

4.  Predictive cytogenetic biomarkers for colorectal neoplasia in medium risk patients.

Authors:  E M Ionescu; T Nicolaie; M A Ionescu; G Becheanu; F Andrei; M Diculescu; M Ciocirlan
Journal:  J Med Life       Date:  2015 Jul-Sep

5.  Retrospective Biological Dosimetry at Low and High Doses of Radiation and Radioiodine Impact on Individual Susceptibility to Ionizing Radiation.

Authors:  Antonina Cebulska-Wasilewska; Mateusz Krzysiek; Grażyna Krajewska; Artur Stępień; Paweł Krajewski
Journal:  Genome Integr       Date:  2017-01-23

6.  Micronuclei Formation upon Radioiodine Therapy for Well-Differentiated Thyroid Cancer: The Influence of DNA Repair Genes Variants.

Authors:  Luís S Santos; Octávia M Gil; Susana N Silva; Bruno C Gomes; Teresa C Ferreira; Edward Limbert; José Rueff
Journal:  Genes (Basel)       Date:  2020-09-17       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.